Ozempic® has gained significant recognition as an effective treatment for managing blood sugar levels in adults diagnosed with type 2 diabetes, especially when combined with a balanced diet and regular exercise. Furthermore, it’s FDA-approved to reduce the risk of major cardiovascular events like heart attacks and strokes in adults who have both type 2 diabetes and cardiovascular disease. It’s important to note that Ozempic® is not suitable for individuals with type 1 diabetes.
Recognizing that every patient’s needs are unique, we are dedicated to providing personalized healthcare solutions. While Ozempic® (semaglutide) is a preferred choice for many, we understand the importance of having alternative treatments available to ensure everyone can access the most appropriate medication. Depending on availability and individual patient needs, our experienced online doctors may suggest or prescribe other GLP-1 receptor agonists to manage type 2 diabetes. These alternatives include:
-
Rybelsus® (semaglutide): For patients who prefer oral medication, Rybelsus® offers the same active ingredient as Ozempic® in a convenient pill form. This oral GLP-1 medication provides effective blood sugar control without the need for injections.
-
Trulicity® (dulaglutide): Trulicity® is administered as a once-weekly injection and is well-regarded for its ease of use. The pre-filled, disposable pen makes it a user-friendly option for weekly diabetes management.
-
Bydureon® (exenatide): Bydureon® stands out with its extended-release formula, requiring only once-weekly injections. This less frequent dosing schedule can be a significant advantage for many individuals managing their type 2 diabetes.
*In situations where branded medications are unavailable due to FDA shortages, compounded semaglutide prescriptions may be considered. These compounded medications are prepared by our trusted state-licensed sterile compounding pharmacy partner, adhering to all federal and state regulations, including FDA guidelines. However, it’s crucial to understand that compounded semaglutide, like all compounded drugs, is not FDA-approved and does not undergo the same rigorous FDA review process for safety, effectiveness, and manufacturing as branded medications. Prescriptions for compounded semaglutide are currently available to residents in AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, KS, MA, MD, ME, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, TN, TX, UT, VA, VT, WA, WI, WV, Washington D.C., and WY.
